Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer

MicroRNAs (miRNAs) are small molecules of single strand non-coding RNAs, which are able to regulate gene expression. miRNAs have been involved in multiple cellular processes, such as proliferation, apoptosis and differentiation, thus alterations in miRNA expression have been shown to be directly linked with the pathological origin of multiple diseases, including cancer. In this way, during last few years, an increasing number of exciting advances have contributed to the understanding of miRNA roles in cancer. Moreover, researchers have exploited the special characteristics of miRNAs, such as the tissue and disease specificity or miRNA presence in blood, to explore their use as non-invasive tumour markers. In the present review, we summarize the current data on the potential usefulness of circulating miRNAs as diagnostic and prognostic tools in gastrointestinal tumours.

[1]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[2]  Xinjun Zhang,et al.  Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker , 2010, Journal of Molecular Medicine.

[3]  Yoshiki Murakami,et al.  MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  Tongyu Lin,et al.  Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.

[5]  T Kawaguchi,et al.  Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma , 2012, British Journal of Cancer.

[6]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[7]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[8]  Megan F. Cole,et al.  Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells , 2008, Cell.

[9]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[10]  D. Ichikawa,et al.  Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.

[11]  M. Nykter,et al.  Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.

[12]  Longgui Wang,et al.  Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.

[13]  D. Kang,et al.  Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer , 2012, PloS one.

[14]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[15]  Tao Jiang,et al.  Circulating microRNAs in cancer: origin, function and application , 2012, Journal of Experimental & Clinical Cancer Research.

[16]  Zheng Wang,et al.  Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Boland,et al.  Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[18]  W. Tan,et al.  Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis , 2011, Molecular Carcinogenesis.

[19]  Xi Chen,et al.  Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. , 2012, Clinical chemistry.

[20]  H. Qian,et al.  Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. , 2012, Molecular medicine reports.

[21]  Li-ping Guo,et al.  The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. , 2011, Clinical science.

[22]  R. Russell,et al.  Principles of MicroRNA–Target Recognition , 2005, PLoS biology.

[23]  Zhaohui Huang,et al.  Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.

[24]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[25]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[26]  Dieter Jocham,et al.  A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. , 2010, Urologic oncology.

[27]  H. S. Wolff,et al.  iRun: Horizontal and Vertical Shape of a Region-Based Graph Compression , 2022, Sensors.

[28]  Ann M. Killary,et al.  MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.

[29]  P. Qi,et al.  Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection , 2011, PloS one.

[30]  Yu Liang,et al.  BMC Genomics , 2007 .

[31]  D. Ichikawa,et al.  Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer , 2011, British Journal of Cancer.

[32]  Wei Zhang,et al.  Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. , 2012, Cancer letters.

[33]  T. Leung,et al.  Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.

[34]  Peng-jun Zhang,et al.  Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.

[35]  R. Aharonov,et al.  MicroRNAs accurately identify cancer tissue origin , 2008, Nature Biotechnology.

[36]  Erin K Hanson,et al.  Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. , 2009, Analytical biochemistry.

[37]  Xi Chen,et al.  Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.

[38]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[39]  Xi Chen,et al.  A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.

[40]  Seena K. Ajit Circulating microRNAs as Biomarkers, Therapeutic Targets, and Signaling Molecules , 2012, Sensors.

[41]  X. Chen,et al.  Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. , 2010, Cancer research.

[42]  D. Ichikawa,et al.  Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.

[43]  Y. Gong,et al.  Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis , 2011, Digestive Diseases and Sciences.

[44]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[45]  M. Albitar,et al.  Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma , 2011, Journal of clinical gastroenterology.

[46]  Hermann Brenner,et al.  Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review , 2007, Cancer Epidemiology Biomarkers & Prevention.

[47]  Wanjun Yu,et al.  Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. , 2011, Biochemical and biophysical research communications.

[48]  I. Mittra,et al.  Nucleic acids in circulation: Are they harmful to the host? , 2012, Journal of Biosciences.

[49]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[50]  Y. Gong,et al.  Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.